Antimicrobial Susceptibility Test Kits Research:the global top three players had a share approximately 58.0% in terms of revenue

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Antimicrobial Susceptibility Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Antimicrobial Susceptibility Test Kits market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Antimicrobial Susceptibility Test Kits was estimated to be worth US$ 1682 million in 2024 and is forecast to a readjusted size of US$ 2919 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5489199/antimicrobial-susceptibility-test-kits

Antimicrobial Susceptibility Test Kits Market Summary

I. Industry Chain Analysis of Antimicrobial Susceptibility Test (AST) Kits

The industrial chain of Antimicrobial Susceptibility Test (AST) kits encompasses a comprehensive ecosystem ranging from upstream raw material suppliers, reagent producers, and instrument manufacturers to distribution networks and end users. Each segment plays a crucial role in ensuring product accuracy, reliability, and scalability across the global diagnostic market.

Upstream Segment:

This segment primarily consists of suppliers of biological reagents, chemical raw materials, microbial strains, and culture media producers. The key raw materials include agar, tryptone, soya peptone, amino acids, antibiotic reference standards, and base media ingredients. The quality and consistency of these components determine the reproducibility and accuracy of AST results. Among them, antibiotic standards and certain growth components require high-purity chemical synthesis and precise microbial formulations, often dominated by specialized manufacturers in the United States, Europe, and Japan.

Midstream Segment:

These companies have been driving innovation by shifting from the traditional Kirby-Bauer disk diffusion method toward automated microdilution techniques, E-test, and molecular-based AST systems. Integration of automation, robotics, and AI-enabled image recognition systems has allowed faster interpretation and reduced human error. Furthermore, the digitalization of AST results enables data networking and real-time feedback, enhancing infection control and antibiotic stewardship programs.

Downstream Segment:

AST kits are primarily utilized in clinical microbiology laboratories, disease control centers, third-party diagnostic laboratories, research institutes, and pharmaceutical R&D divisions. Hospitals account for the largest consumption share, representing over 60% of the total market. With the rapid increase of multidrug-resistant (MDR) bacteria and hospital-acquired infections (HAIs), the demand for rapid AST has surged. Pharmaceutical companies use AST data for antibiotic discovery and validation, while research institutions focus on the epidemiology of resistance genes.

Overall, the AST industry chain is characterized by high technological barriers, strict regulatory oversight, and a moderate-to-high market concentration. The upstream segment provides specialized biochemical materials, the midstream focuses on system development and reagent formulation, and the downstream connects to critical clinical and public health applications. Interdisciplinary collaboration across microbiology, chemistry, and data informatics is vital to maintaining performance consistency and regulatory compliance.

Figure00001. Global Antimicrobial Susceptibility Test Kits Market Size (US$ Million), 2020-2031

Antimicrobial Susceptibility Test Kits

Above data is based on report from QYResearch: Global Antimicrobial Susceptibility Test Kits Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

Figure00002. Global Antimicrobial Susceptibility Test Kits Top 10 Players Ranking and Market Share (Ranking is based on the revenue of 2024, continually updated)

Antimicrobial Susceptibility Test Kits

Above data is based on report from QYResearch: Global Antimicrobial Susceptibility Test Kits Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of Antimicrobial Susceptibility Test Kits include bioMérieux SA, Thermo Fisher Scientific Inc., etc. In 2023, the global top three players had a share approximately 58.0% in terms of revenue.

II. Development Trends, Opportunities, and Challenges

(1) Development Trends

The global AST market is evolving toward rapid, automated, digitized, and precision-based testing. Traditional culture-based methods typically require 24-48 hours, whereas next-generation technologies-including genomic sequencing, nanotechnology biosensors, and optical detection systems-can deliver results within hours or even minutes. Artificial intelligence (AI) and machine learning models are being increasingly integrated to interpret zone diameters or growth curves, enhancing result accuracy and reproducibility.

Another significant trend is data integration and digital management. Modern AST systems now link seamlessly to hospital information systems (HIS) and laboratory information systems (LIS), forming real-time databases for antimicrobial resistance (AMR) surveillance. This trend aligns with global initiatives like the WHO Global Antimicrobial Resistance Surveillance System (GLASS) and CDC's Antibiotic Resistance Solutions Initiative, both of which promote standardization and cross-border data exchange.

Microfluidics and molecular AST platforms are reshaping diagnostic workflows. Miniaturized chip-based systems enable high-throughput, parallel testing across multiple antibiotics, substantially shortening turnaround time and improving clinical outcomes in critical settings like ICUs and emergency departments.

(2) Market Opportunities

The worsening global antibiotic resistance crisis represents the primary driver of AST market expansion. According to the World Health Organization, approximately 1.2 million people die annually from drug-resistant infections, with projections suggesting that number could reach 10 million by 2050 if unchecked. Governments and healthcare systems are increasingly investing in rapid diagnostic tools for antibiotic stewardship, providing a sustained market opportunity for AST kit manufacturers.

In addition, emerging economies in Asia-Pacific, Latin America, and the Middle East are upgrading healthcare infrastructure and laboratory capacity. This creates new demand for affordable, automated AST kits compatible with local diagnostic systems. In China, national policies promoting tiered healthcare reform and hospital infection control programs have driven the adoption of AST testing in secondary and county-level hospitals, further expanding market coverage.

(3) Industry Challenges

Despite growth potential, several major challenges constrain the industry:

Lack of global standardization: International variations between CLSI (U.S.) and EUCAST (Europe) methodologies lead to inconsistent interpretation criteria and cross-border trade complexities.

Regulatory burdens: Obtaining in vitro diagnostic (IVD) certifications such as FDA 510(k), CE-IVD, or China NMPA requires extensive clinical validation, raising time and cost barriers.

Technical complexity: The convergence of microbiology, materials science, and computational modeling demands multidisciplinary expertise and continuous R&D investment.

Market concentration: A few multinational corporations dominate the segment, leaving limited room for small and mid-sized enterprises to penetrate hospital procurement systems.

In conclusion, while the AST market is poised for high growth, it will continue to be shaped by dual forces-technological innovation and regulatory compliance-driving a competitive yet highly structured industry landscape.

III. Downstream Industry Analysis

AST kits serve a wide array of downstream sectors, including:

Healthcare institutions (hospitals and clinical labs);

Independent diagnostic laboratories (third-party testing);

Pharmaceutical and biotech R&D;

Public health and disease control agencies;

Academic and research institutions.

Among these, hospitals represent the largest end-user group. Within clinical settings, AST testing is fundamental for infection control, antimicrobial stewardship, and therapeutic decision-making. Automated AST systems are now considered essential infrastructure in microbiology laboratories of tertiary hospitals. With the expansion of national AMR surveillance networks such as China's CARSS, more secondary and regional hospitals are adopting AST testing capacity to comply with infection control mandates.

Independent testing laboratories (e.g., KingMed Diagnostics, Dian Diagnostics, BGI) have become major growth drivers, providing outsourced AST services to small and mid-sized hospitals lacking in-house capabilities. These labs emphasize throughput, cost efficiency, and digital reporting.

Pharmaceutical companies rely on AST kits for antibiotic efficacy evaluation during preclinical and clinical stages of drug development. Accurate sensitivity data inform compound optimization, MIC testing, and resistance mechanism studies.

Public health institutions use AST data for epidemiological surveillance and resistance mapping. The global fight against AMR increasingly depends on AST-based analytics for outbreak tracking and policy formulation.

In summary, the downstream demand for AST kits has expanded from traditional clinical diagnostics to encompass pharmaceutical research, academic investigation, and national health governance. This multidimensional demand structure ensures the long-term stability and diversification of the market.

IV. Entry Barriers

The AST kit industry is characterized by high entry barriers that restrict new entrants. The primary obstacles include:

Technological Barriers: Developing high-performance AST systems requires expertise across microbiology, chemical synthesis, precision engineering, and AI data interpretation. Establishing reliable susceptibility testing systems demands years of R&D and substantial validation datasets.

Regulatory and Certification Barriers: Products must undergo rigorous IVD regulatory approvals (FDA, CE, NMPA, etc.), which involve extended evaluation cycles, clinical trials, and compliance documentation.

Brand and Trust Barriers: Hospitals and laboratories prioritize established brands with proven clinical reliability. Gaining inclusion in hospital procurement catalogs requires long-term data accumulation and credibility.

Capital Barriers: Development costs-including prototype design, clinical trials, and global distribution-are substantial, limiting market access for smaller companies.

Distribution Barriers: Building an international logistics and after-sales support network is complex and resource-intensive.

Standardization Barriers: Divergent global testing standards (CLSI vs. EUCAST) require region-specific validation, adding cost and time.

As a result, market entry without strong technological differentiation, regulatory expertise, or financial backing is extremely difficult. Global leaders continue to consolidate their positions through product innovation, global certification strategies, and partnerships with major healthcare systems.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Antimicrobial Susceptibility Test Kits market is segmented as below:
By Company
bioMérieux SA
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company (BD)
Merck KGaA (MilliporeSigma)
HiMedia Laboratories
Liofilchem S.r.l.
Accelerate Diagnostics, Inc.
Biotron Healthcare
Beijing ZONCI Technology Co., Ltd.
Hardy Diagnostics

Segment by Type
Bacterial
Fungal
Mixed Infections

Segment by Application
Pharmaceuticals
Food
Other

Each chapter of the report provides detailed information for readers to further understand the Antimicrobial Susceptibility Test Kits market:

Chapter 1: Introduces the report scope of the Antimicrobial Susceptibility Test Kits report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of Antimicrobial Susceptibility Test Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various Antimicrobial Susceptibility Test Kits market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of Antimicrobial Susceptibility Test Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of Antimicrobial Susceptibility Test Kits in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Antimicrobial Susceptibility Test Kits competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Antimicrobial Susceptibility Test Kits comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Antimicrobial Susceptibility Test Kits market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global Antimicrobial Susceptibility Test Kits Market Outlook, In‐Depth Analysis & Forecast to 2031
Global Antimicrobial Susceptibility Test Kits Market Research Report 2025
Global Antimicrobial Susceptibility Test Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.